Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

362 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Updated international consensus report on the investigation and management of primary immune thrombocytopenia.
Provan D, Arnold DM, Bussel JB, Chong BH, Cooper N, Gernsheimer T, Ghanima W, Godeau B, González-López TJ, Grainger J, Hou M, Kruse C, McDonald V, Michel M, Newland AC, Pavord S, Rodeghiero F, Scully M, Tomiyama Y, Wong RS, Zaja F, Kuter DJ. Provan D, et al. Among authors: newland ac. Blood Adv. 2019 Nov 26;3(22):3780-3817. doi: 10.1182/bloodadvances.2019000812. Blood Adv. 2019. PMID: 31770441 Free PMC article.
Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group.
Rodeghiero F, Michel M, Gernsheimer T, Ruggeri M, Blanchette V, Bussel JB, Cines DB, Cooper N, Godeau B, Greinacher A, Imbach P, Khellaf M, Klaassen RJ, Kühne T, Liebman H, Mazzucconi MG, Newland A, Pabinger I, Tosetto A, Stasi R. Rodeghiero F, et al. Blood. 2013 Apr 4;121(14):2596-606. doi: 10.1182/blood-2012-07-442392. Epub 2013 Jan 29. Blood. 2013. PMID: 23361904 Free article.
Romiplostim in adult patients with newly diagnosed or persistent immune thrombocytopenia (ITP) for up to 1 year and in those with chronic ITP for more than 1 year: a subgroup analysis of integrated data from completed romiplostim studies.
Kuter DJ, Newland A, Chong BH, Rodeghiero F, Romero MT, Pabinger I, Chen Y, Wang K, Mehta B, Eisen M. Kuter DJ, et al. Br J Haematol. 2019 May;185(3):503-513. doi: 10.1111/bjh.15803. Epub 2019 Feb 21. Br J Haematol. 2019. PMID: 30793285 Free PMC article. Clinical Trial.
Immune thrombocytopenia.
Bussel J, Cooper N, Boccia R, Zaja F, Newland A. Bussel J, et al. Expert Rev Hematol. 2021 Nov;14(11):1013-1025. doi: 10.1080/17474086.2021.1995347. Epub 2021 Nov 18. Expert Rev Hematol. 2021. PMID: 34720027
International consensus report on the investigation and management of primary immune thrombocytopenia.
Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, Chong BH, Cines DB, Gernsheimer TB, Godeau B, Grainger J, Greer I, Hunt BJ, Imbach PA, Lyons G, McMillan R, Rodeghiero F, Sanz MA, Tarantino M, Watson S, Young J, Kuter DJ. Provan D, et al. Among authors: newland ac. Blood. 2010 Jan 14;115(2):168-86. doi: 10.1182/blood-2009-06-225565. Epub 2009 Oct 21. Blood. 2010. PMID: 19846889 Free article. Review.
Immune thrombocytopenia -- what are the new treatment options?
Hallam S, Provan D, Newland AC. Hallam S, et al. Among authors: newland ac. Expert Opin Biol Ther. 2013 Aug;13(8):1173-85. doi: 10.1517/14712598.2013.801451. Epub 2013 May 17. Expert Opin Biol Ther. 2013. PMID: 23682685 Review.
Current Management of Primary Immune Thrombocytopenia.
Provan D, Newland AC. Provan D, et al. Among authors: newland ac. Adv Ther. 2015 Oct;32(10):875-87. doi: 10.1007/s12325-015-0251-z. Epub 2015 Oct 26. Adv Ther. 2015. PMID: 26499177 Free PMC article. Review.
362 results